Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)

被引:22
作者
Funk, Markus B. [1 ]
Heiden, Margarethe [2 ]
Volkers, Peter [3 ]
Lohmann, Annette [1 ]
Keller-Stanislawski, Brigitte [1 ]
机构
[1] Paul Ehrlich Inst, Div Safety Med Prod & Med Devices, D-63225 Langen, Germany
[2] Paul Ehrlich Inst, Div Transfus Med, D-63225 Langen, Germany
[3] Paul Ehrlich Inst, Sect Biostat, D-63225 Langen, Germany
关键词
Reporting rate; Risk minimisation measures; Blood components; Transfusion reaction; Haemovigilance; ACUTE LUNG INJURY; REDUCTION; PLASMA;
D O I
10.1159/000381996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the impact of safety measures, we compared reporting rates of transfusion-related reactions before and after the implementation of six measures in 1999, 2004, 2006, 2008 and 2009. Methods: Reporting rates of transfusion-transmitted bacterial infection (TTBI), viral infection (TTVI) and immune-mediated transfusion-related acute lung injury (TRALI) were calculated on the basis of confirmed annual reports and distributed blood components. Results: The introduction of HCV NAT testing caused a significant reduction of HCV reporting rate from 1:0.6 to 1:83.16 million administered blood components (p < 0.0001), donor screening for antibodies to hepatitis B core antigen caused a reduction of HBV reporting rate from 1:2.90 to 1:10.70 million units (p = 0.0168). A significant reduction from 1:0.094 to 1:2.42 million fresh frozen plasma (FFP) units could also be achieved by risk minimisation TRALI measures (p < 0.0001). Implementation of pre-donation sampling did not result in a significant decrease in TTBI, whereas limitation of shelf life for platelet concentrate (PC) minimised the TTBI reporting rate from 1:0.088 to 1:0.19 million PC units (p = 0.041). For HIV NAT pool testing, no significant reduction in HIV transmission was found due to very low reporting rates (1:10 million versus 1:27 million blood components, p = 0.422). Conclusion: On the basis of haemovigilance data, a significant benefit could be demonstrated for four of six implemented safety measures. (C) 2015 S. Karger GmbH, Freiburg
引用
收藏
页码:240 / 246
页数:7
相关论文
共 19 条
[11]   A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States [J].
Kleinman, Steven ;
Grossman, Brenda ;
Kopko, Patricia .
TRANSFUSION, 2010, 50 (06) :1312-1321
[12]  
Lin Y, 2009, TRANSFUSION, V49, p47A
[13]   Report on the Fourth International Granulocyte Immunology Workshop: Progress toward quality assessment [J].
Lucas, G ;
Rogers, S ;
de Haas, M ;
Porcelijn, L ;
Bux, J .
TRANSFUSION, 2002, 42 (04) :462-468
[14]   Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions [J].
Nuebling, C. Micha ;
Heiden, Margarethe ;
Chudy, Michael ;
Kress, Julia ;
Seitz, Rainer ;
Keller-Stanislawski, Brigitte ;
Funk, Markus B. .
TRANSFUSION, 2009, 49 (09) :1850-1858
[15]  
R Project for Statistical Computing, 2013, R LANG ENV STAT COMP
[16]   Causality assessment of suspected virus transmission by human plasma products [J].
Schosser, R ;
Keller-Stanislawski, B ;
Nübling, CM ;
Löwer, J .
TRANSFUSION, 2001, 41 (08) :1020-1029
[17]   Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? [J].
Vollmer, Tanja ;
Schottstedt, Volkmar ;
Bux, Juergen ;
Walther-Wenke, Gabriele ;
Knabbe, Cornelius ;
Dreier, Jens .
BLOOD TRANSFUSION, 2014, 12 (03) :388-395
[18]   Transfusion-transmitted bacterial infection: risks, sources and interventions [J].
Wagner, SJ .
VOX SANGUINIS, 2004, 86 (03) :157-163
[19]   Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures [J].
Walther-Wenke, G. ;
von Koenig, C. H. Wirsing ;
Daeubener, W. ;
Heiden, M. ;
Hoch, J. ;
Hornei, B. ;
Volkers, P. .
VOX SANGUINIS, 2011, 100 (04) :359-366